Skip to main content
SpringerLink
Log in

Application value of computer-assisted surgery system in pediatric hepatic hemangioma

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Purpose

To explore the treatment of pediatric hepatic hemangioma and the role of the Hisense computer-assisted surgery (Hisense CAS) system in diagnosis and treatment.

Methods

We collected the clinical and follow-up data of all pediatric hepatic hemangioma cases in our pediatric surgery department from March 2008 to March 2021 for retrospective analysis. The Hisense CAS system was used to create three-dimensional (3D) reconstructions based on computed tomography data.

Results

There were 71 patients, mainly infants (prenatal to 39 months). There were more males than females (42 vs. 29), and the alpha-fetoprotein level was significantly increased in 8 cases. 3D reconstruction by the Hisense CAS system showed that hepatic artery tracking was helpful for the differential diagnosis of pediatric hepatic hemangioma. Twenty-three children treated with propranolol showed significant differences in the tumour diameter, volume, and tumour-to-liver volume ratio after treatment (all P < 0.05). Compared with early surgical treatment, the curative effect of this approach was obvious.

Conclusion

As a non-surgical treatment for symptomatic pediatric hepatic hemangioma, propranolol can replace surgical resection to a certain extent and reduce the proportion of children who need surgical intervention. Hisense CAS has advantages in evaluating the tumour volume before and after propranolol treatment. The liver volume and the liver tumour volume percentage provide new perspectives for evaluating the tumour outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Iacobas I, Phung TL, Adams DM et al (2018) Guidance document for hepatic hemangioma (infantile and congenital) evaluation and monitoring. J Pediatr 203:294–300. https://doi.org/10.1016/j.jpeds.2018.08.012

    Article  PubMed  Google Scholar 

  2. Gnarra M, Behr G, Kitajewski A et al (2016) History of the infantile hepatic hemangioma: from imaging to generating a differential diagnosis. World J Clin Pediatr 5(3):273–280. https://doi.org/10.5409/wjcp.v5.i3.273

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zhang XT, Ren WD, Song G et al (2019) Infantile hepatic hemangiomas associated with high-output cardiac failure and pulmonary hypertension. BMC Cardiovasc Disord 19(1):216. https://doi.org/10.1186/s12872-019-1200-6

    Article  PubMed  PubMed Central  Google Scholar 

  4. Zhao J, Zhou XJ, Zhu CZ et al (2017) 3D simulation assisted resection of giant hepatic mesenchymal hamartoma in children. Comput Assist Surg 22(1):54–59. https://doi.org/10.1080/24699322.2017.1358401

    Article  Google Scholar 

  5. Su L, Dong Q, Zhang H et al (2016) Clinical application of a three-dimensional imaging technique in infants and young children with complex liver tumors. Pediatr Surg Int 32(4):387–395. https://doi.org/10.1007/s00383-016-3864-7

    Article  PubMed  Google Scholar 

  6. Drolet BA, Frommelt PC, Chamlin SL et al (2013) Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 131(1):128–140. https://doi.org/10.1542/peds.2012-1691

    Article  PubMed  PubMed Central  Google Scholar 

  7. Yang K, Peng S, Chen L et al (2019) Efficacy of propranolol treatment in infantile hepatic hemangioma. J Paediatr Child Health 55(10):1194–1200. https://doi.org/10.1111/jpc.14375

    Article  PubMed  Google Scholar 

  8. Varrasso G, Schiavetti A, Lanciotti S, Sapio M, Ferrara E, De Grazia A, Clerico A (2017) Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: a case report. Hepatology 66(1):283–285. https://doi.org/10.1002/hep.29028

    Article  PubMed  Google Scholar 

  9. Zhang G, Zhou XJ, Zhu CZ et al (2016) Usefulness of three-dimensional (3D) simulation software in hepatectomy for pediatric hepatoblastoma. Surg Oncol 25(3):236–243. https://doi.org/10.1016/j.suronc.2016.05.023

    Article  PubMed  Google Scholar 

  10. Qureshi SS, Bhagat M, Kembhavi S et al (2015) Benign liver tumors in children: outcomes after resection. Pediatr Surg Int 31(12):1145–1149. https://doi.org/10.1007/s00383-015-3763-3

    Article  PubMed  Google Scholar 

  11. Sana L, Betalli P, Bravi M et al (2021) Hepatic hemangioendothelioma of infancy: clinical features of a large cohort of patients and proposed management. Pediatr Surg Int. https://doi.org/10.1007/s00383-021-04860-y

    Article  PubMed  Google Scholar 

  12. Emad A, Fadel S, El Wakeel M et al (2020) Outcome of children treated for infantile hepatic hemangioendothelioma. J Pediatr Hematol Oncol 42(2):126–130. https://doi.org/10.1097/MPH.0000000000001536

    Article  PubMed  Google Scholar 

  13. Kim KH, Choi TH, Choi Y et al (2017) Comparison of efficacy and safety between propranolol and steroid for infantile hemangioma: a randomized clinical trial. JAMA Dermatol 153(6):529–536. https://doi.org/10.1001/jamadermatol.2017.0250

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lou Y, Peng WJ, Cao Y et al (2014) The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol 78(1):44–57. https://doi.org/10.1111/bcp.12235

    Article  PubMed  CAS  Google Scholar 

  15. Léaute-labrèze C, Boccara O, Degrugillier-chopinet C et al (2016) Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Pediatrics 138(4):e20160353. https://doi.org/10.1542/peds.2016-0353

    Article  PubMed  Google Scholar 

  16. Tian R, Liang Y, Wang J et al (2020) Propranolol for infantile hepatic hemangioendothelioma: clinical evaluation of drug efficacy and safety using a single-center patient cohort. Ann Hepatol 19(5):530–534. https://doi.org/10.1016/j.aohep.2020.04.008

    Article  PubMed  CAS  Google Scholar 

  17. Macdonald A, Durkin N, Deganello A et al (2020) Historical and contemporary management of infantile hepatic hemangioma: a 30-year single-center experience. Ann Surg. https://doi.org/10.1097/SLA.0000000000003881

    Article  PubMed  Google Scholar 

  18. Zavras N, Dimopoulou A, Machairas N et al (2020) Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 179(1):1–8. https://doi.org/10.1007/s00431-019-03504-7

    Article  PubMed  Google Scholar 

  19. Pan FS, Xu M, Wang W et al (2013) Infantile hepatic hemangioendothelioma in comparison with hepatoblastoma in children: clinical and ultrasound features. Hepat Mon 13(8):e11103. https://doi.org/10.5812/hepatmon.11103

    Article  PubMed  PubMed Central  Google Scholar 

  20. Xu M, Pan FS, Wang W et al (2018) The value of clinical and ultrasound features for the diagnosis of infantile hepatic hemangioma: comparison with contrast-enhanced CT/MRI. Clin Imaging 51:311–317. https://doi.org/10.1016/j.clinimag.2018.06.017

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Funding was provided by Qingdao People's Livelihood Science and technology Project [Grant No. 17-3-3-8-nsh].

Author information

Authors and Affiliations

  1. Department of Pediatric Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China

    Wenli Xiu, Tong Li, Xiwei Hao, Hong Liu, Yuhe Duan, Zhong Jiang, Cong Shang & Qian Dong

  2. Department of Pediatric Surgery, Yijishan Hospital of Wannan Medical College, Wannan Medical College, Wuhu, 241000, China

    Jie Liu

  3. Shandong Provincial Key Laboratory of Digital Medicine and Computer-Assisted Surgery, Shandong College Collaborative Innovation Center of Digital Medicine Clinical Treatment and Nutrition Health, Qingdao, 266003, China

    Hong Liu, Nan Xia & Qian Dong

Authors
  1. Wenli Xiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiwei Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nan Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuhe Duan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhong Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Cong Shang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Qian Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qian Dong.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiu, W., Liu, J., Li, T. et al. Application value of computer-assisted surgery system in pediatric hepatic hemangioma. Pediatr Surg Int 37, 1575–1583 (2021). https://doi.org/10.1007/s00383-021-04972-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-021-04972-5

Keywords

Search

Navigation